Anlon Healthcare to acquire 67.48% shareholding in Apiqo Organics

02 Dec 2025 Evaluate

Anlon Healthcare has entered into a Share Purchase Agreement (SPA) with Apiqo Organics (formerly known as M/s Apple Life Science, a partnership firm) (Target Company) for acquisition of 67.48% shareholding of the Target Company from 3 shareholders of such Target Company, in accordance with and subject to the terms and conditions as set out in the SPA.

Pursuant to the terms of the SPA and upon fulfilment of the conditions precedent contained in the SPA, Purchaser being the Company will acquire management and control of the Target Company, and upon completion of such acquisition, the Target Company will become Subsidiary of the Company.

The proposed strategic acquisition of the Target Company significantly enhances the Company’s vertical integration, secures critical supply of high-quality intermediates, increases additional 700 to 800 MT annual manufacturing capacity for advanced pharmaceutical intermediates, and strengthens the ability of the Company to deliver reliable, cost-effective solutions to its global pharmaceutical partners. The proposed acquisition not only secures supply of critical materials for the Company but also positions it as a more agile, cost-competitive, and reliable partner for innovator and generic pharmaceutical companies worldwide.

Anlon Healthcare is a chemical manufacturing company engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in India and international markets.

Anlon Healthcare Share Price

151.90 -1.50 (-0.98%)
05-Dec-2025 11:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1280.00
Cipla 1521.35
Zydus Lifesciences 933.80
Lupin 2100.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×